Cargando…
Omadacycline Enters the Ring: A New Antimicrobial Contender
Omadacycline is a novel aminomethylcycline approved for the treatment of community‐acquired bacterial pneumonia and acute bacterial skin and skin structure infections. This article reviews existing data pertaining to the biochemistry, mechanism of action, pharmacokinetics/pharmacodynamics, in vitro...
Autores principales: | Barber, Katie E., Bell, Alison M., Wingler, Mary Joyce B., Wagner, Jamie L., Stover, Kayla R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587716/ https://www.ncbi.nlm.nih.gov/pubmed/30290000 http://dx.doi.org/10.1002/phar.2185 |
Ejemplares similares
-
An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy
por: Bradley, Abby C., et al.
Publicado: (2023) -
Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application
por: Barber, Katie E., et al.
Publicado: (2016) -
General Principles of Antimicrobial Therapy
por: Leekha, Surbhi, et al.
Publicado: (2011) -
597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
por: Wingler, Mary Joyce B, et al.
Publicado: (2018) -
Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center
por: Markovich, Kylie, et al.
Publicado: (2022)